RA
CELG

RiverPark Advisors’s Celgene Corp CELG Stock Holding History

RiverPark Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-34,110
Closed -$3.39M – 56
2019
Q3 		$3.39M Sell
34,110
-5,108
-13% -$485K 1.54% 27
2019
Q2 		$3.63M Sell
39,218
-4,620
-11% -$439K 1.55% 24
2019
Q1 		$4.14M Sell
43,838
-5,765
-12% -$504K 1.8% 19
2018
Q4 		$3.18M Sell
49,603
-73,310
-60% -$5.41M 1.39% 28
2018
Q3 		$11M Sell
122,913
-56,087
-31% -$4.96M 2.63% 12
2018
Q2 		$14.2M Hold
179,000
– – 2.88% 15
2018
Q1 		$16M Sell
179,000
-38,000
-18% -$3.65M 3.07% 14
2017
Q4 		$22.6M Buy
217,000
+90,000
+71% +$10.2M 3.24% 15
2017
Q3 		$18.5M Sell
127,000
-38,000
-23% -$5.18M 2.44% 19
2017
Q2 		$21.4M Sell
165,000
-27,000
-14% -$3.31M 2.44% 19
2017
Q1 		$23.9M Buy
+192,000
New +$23M 1.58% 20

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

RiverPark Advisors's CELG Position: Q4 2019 in Review

RiverPark Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 34,110 shares — an estimated $3.39M sold.

RiverPark Advisors first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $23.9M in Q1 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • RiverPark Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • RiverPark Advisors sold 34,110 Celgene Corp shares in Q4 2019, an estimated $3.39M.
  • RiverPark Advisors first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • RiverPark Advisors's Celgene Corp position peaked at $23.9M in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on RiverPark Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.